Tell your friends about this item:
Biosimilarity: The FDA Perspective Sarfaraz K. Niazi 1st edition
Price
HK$ 2,132
excl. VAT
Ordered from remote warehouse
Expected to be ready for shipping Aug 5 - 17
Get notified about new Sarfaraz K. Niazi releases
Our customers say:
Add to your iMusic wish list
Biosimilarity: The FDA Perspective
Sarfaraz K. Niazi
The focus of this book is on how the US FDA will approve biosimilar drugs. The European scene is well developed with specific guidelines that are already in place. However, these guidelines do not apply to the thinking of the FDA in approving these products.
456 pages, 79 colour illustrations, 43 black & white tables
| Media | Books Hardcover Book (Book with hard spine and cover) |
| Released | July 25, 2018 |
| ISBN13 | 9781498750394 |
| Publishers | Taylor & Francis Inc |
| Pages | 398 |
| Dimensions | 261 × 187 × 29 mm · 1.10 kg |
| Language | English |
More by Sarfaraz K. Niazi
Show all
More from the same publisher
See all of Sarfaraz K. Niazi ( e.g. Paperback Book , Hardcover Book and Book pack )